Handbook of Clinical medicine

eff ectively treat concurrent scabies. Cutaneous leishmaniasis Most common form of leishmaniasis. Esti- mated 0.7–1.3 million new cases/yr: Americas, Mediterranean basin, north Africa, Middle East, central Asia. Presentation: Lesions develop at the bite site, beg i nning as an itchy papule; crusts fall off to leave a pain- less ulcer with a well-defi ned, raised border and a crusted base = ‘Chiclero’s ulcer’ (fi g 9.56). Diagnosis: Skin biopsy + PCR. Treat- ment: Most heal in ~2–15 months with scar- ring (disfi guring if extensive). ‘New World‘ disease (South America) needs treating due Fig 9.56 Cutaneous leishmaniasis with cen- to risk of mucocutaneous disease: pentava- tral crusting. lent antimony, eg meglumine antimoniate, Reproduced from Lewis-Jones, Paediatric Der- sodium stibogluconate. (See p423.) matology, 2010, with permission from Oxford University Press. __OOHHCCMM__1100ee..iinnddbb 444400 0022//0055//22001177 1199::0088 sesaesid suoitcefnI Myiasis 441 Infection with fl y larvae/maggot. Can aff ect living and necrotic tissue. In south and central America the human botfl y lays its eggs on mosquitoes which de- posit them when they bite. In sub-Sahran Africa the tumbu fl y lays its eggs on clothing which then trans- fer to skin. Presentation: Painful swelling. May have sensation of movement within the lesion. May
